Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Valentina Rigo
Observed name:
Rigo, Valentina
Institution:
Ospedale Policlinico San Martino
Observed institution:
Ospedale Policlinico San Martino
ORCID:
0000-0002-2032-3929
Observed ORCID:
0000-0002-2032-3929
OpenAlex ID:
A5086030364
IL-21: A Pleiotropic Cytokine with Potential Applications in Oncology
2015
·
Michela Croce
, Valentina Rigo
, et al.
·
Journal of Immunology Research
·
105
PDF
Combined immunotherapy with anti-PDL-1/PD-1 and anti-CD4 antibodies cures syngeneic disseminated neuroblastoma
2017
·
Valentina Rigo
, Laura Emionite
, et al.
·
Scientific Reports
·
48
PDF
Guadecitabine increases response to combined anti-CTLA-4 and anti-PD-1 treatment in mouse melanoma in vivo by controlling T-cells, myeloid derived suppressor and NK cells
2023
·
Adriana Amaro
, Francesco Reggiani
, et al.
·
Journal of Experimental & Clinical Cancer Research
·
39
PDF
Transient depletion of CD4+ T cells augments IL‐21‐based immunotherapy of disseminated neuroblastoma in syngeneic mice
2009
·
Michela Croce
, Maria Valeria Corrias
, et al.
·
International Journal of Cancer
·
31
PDF
Recombinant IL-21 and anti-CD4 antibodies cooperate in syngeneic neuroblastoma immunotherapy and mediate long-lasting immunity
2014
·
Valentina Rigo
, Maria Valeria Corrias
, et al.
·
Cancer Immunology Immunotherapy
·
23
Proteomic analysis uncovers common effects of IFN-γ and IL-27 on the HLA class I antigen presentation machinery in human cancer cells
2016
·
Andrea Petretto
, Grazia Carbotti
, et al.
·
Oncotarget
·
22
PDF
IL-10 and ARG-1 Concentrations in Bone Marrow and Peripheral Blood of Metastatic Neuroblastoma Patients Do Not Associate with Clinical Outcome
2015
·
Fabio Morandi
, Michela Croce
, et al.
·
Journal of Immunology Research
·
18
PDF
Altered erythropoiesis and decreased number of erythrocytes in children with neuroblastoma
2017
·
Fabio Morandi
, Sebastiano Barco
, et al.
·
Oncotarget
·
17
PDF
New Immunotherapeutic Strategies for the Treatment of Neuroblastoma
2015
·
Michela Croce
, Maria Valeria Corrias
, et al.
·
Immunotherapy
·
14
Expression ofFOXP3,CD14, andARG1in Neuroblastoma Tumor Tissue from High-Risk Patients Predicts Event-Free and Overall Survival
2015
·
Sara Stigliani
, Michela Croce
, et al.
·
BioMed Research International
·
10
PDF
Immunoregulatory properties of cell free DNA
2025
·
Francesca Ferrera
, Tiziana Altosole
, et al.
·
Cellular and Molecular Life Sciences
·
7
PDF
Assessing Determinants of Response to PARP Inhibition in Germline ATM Mutant Melanoma
2025
·
Eleonora Allavena
, Michela Croce
, et al.
·
International Journal of Molecular Sciences
·
2
PDF
Unveiling the myxofibrosarcoma tumor microenvironment: implications for immunotherapy
2026
·
Cecilia Profumo
, Massimiliano Grassi
, et al.
·
Frontiers in Immunology
·
1
PDF
The Systematic Comparison of Enhancer of Zeste Homolog‐2‐, Bromodomain‐containing Proteins‐, Histone Deacetylase‐, and DNA‐methyltransferase 1‐inhibitors in a Syngeneic Murine Model of Melanoma Reveals Differential Anti‐tumoral and Immunomodulatory Activities
2025
·
Valentina Rigo
, Adriana Amaro
, et al.
·
MedComm
·
1
PDF
Plasma and Pleural Effusion Profiling Reveals Histotype-related Immune Patterns in Pleural Mesothelioma
2026
·
Simona Coco
, Andrea Balossino
, et al.
·
The Journal of Liquid Biopsy
PDF
Reprogramming the tumor microenvironment in mesothelioma: from immune suppression to therapeutic opportunity
2026
·
Luigi Cerbone
, Alessia Garau
, et al.
·
Frontiers in Immunology
PDF
Plasma and Pleural Effusion as reflective mirrors of the Immune Landscape in two histotypes of Pleural Mesothelioma
2025
·
Simona Coco
, Michela Croce
, et al.
·
The Journal of Liquid Biopsy
PDF
Show more works
View as search
Works count:
27
Citation count:
338
H-index:
10
I10-index:
10
Year
Topic
Type